Letermovir Versus Valganciclovir to Prevent Human Cytomegalovirus Disease in Kidney Transplant Recipients (MK-8228-002)
Clinical trial NCT03443869 · COMPLETED
Trial details
- NCT number
- NCT03443869
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-03
- Primary completion
- 2022-04-05
- Enrollment
- 601
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.